US FDA's Medtech Compliance Office Looks Ahead To 2016
This article was originally published in SRA
Executive Summary
The Office of Compliance at the US Food and Drug Administration's device center will put greater emphasis on informal interactions with companies for minor compliance issues, according to Sean Boyd, acting director of the office.